Cargando…
Clinical Relevance of Circulating Tumor Cells in Prostate Cancer Management
Given the low specificity of the routinely used biomarker prostate-specific antigen, circulating tumor cell (CTC) enumeration seems to be particularly useful in the monitoring of prostate cancer. In this review, we focused on a few aspects of CTC enumeration in prostate malignancies: prognostic valu...
Autores principales: | Cieślikowski, Wojciech A., Antczak, Andrzej, Nowicki, Michał, Zabel, Maciej, Budna-Tukan, Joanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471111/ https://www.ncbi.nlm.nih.gov/pubmed/34572366 http://dx.doi.org/10.3390/biomedicines9091179 |
Ejemplares similares
-
Circulating Tumor Cells as a Marker of Disseminated Disease in Patients with Newly Diagnosed High-Risk Prostate Cancer
por: Cieślikowski, Wojciech A., et al.
Publicado: (2020) -
Analysis of Circulating Tumor Cells in Patients with Non-Metastatic High-Risk Prostate Cancer before and after Radiotherapy Using Three Different Enumeration Assays
por: Budna-Tukan, Joanna, et al.
Publicado: (2019) -
Baseline CTC Count as a Predictor of Long-Term Outcomes in High-Risk Prostate Cancer
por: Cieślikowski, Wojciech A., et al.
Publicado: (2023) -
Liquid Biopsy in Melanoma: Significance in Diagnostics, Prediction and Treatment Monitoring
por: Kamińska, Paula, et al.
Publicado: (2021) -
Liquid Biopsy Analysis as a Tool for TKI-Based Treatment in Non-Small Cell Lung Cancer
por: Buszka, Karolina, et al.
Publicado: (2022)